Fact CheckerSign in

NCT06701032Active, not recruiting

Hemodynamic Parameters in People With Atherosclerotic Vascular Disease Referred to a Secondary Prevention and Cardiovascular Rehabilitation Program

Evolution of Hemodynamic Parameters in People With Atherosclerotic Vascular Disease Referred to a Secondary Prevention and Cardiovascular Rehabilitation (PREV) Program: a Prospective Cohort Study.

Source: ClinicalTrials.gov · Last updated 12 Jun 2026

Brief summary (registry, in English)

The main purpose of this study is to evaluate the hemodynamic changes in the forefoot of patients with coronary, cerebrovascular or peripheral atherosclerotic disease referred a 12-week cardiovascular rehabilitation program (PREV program). Also, this study will describe the characteristics of patients admitted to the PREV program and their evolutions in terms of favorable, unfavorable outcomes and complications and up to one year after completion of the program.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
80 (estimated)
First submitted
20 Nov 2024
Start date
25 Nov 2024
Primary completion date
29 Aug 2025
Lead sponsor
Laval University
NCT number
NCT06701032

What you commit to

  • Study type: Interventional
  • Planned participants: 80
  • From 25 Nov 2024 to the primary completion date, 29 Aug 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Being not able to give written informed consent;

Who the study is looking for

  • Any individual aged 18 years and older who has been diagnosed with peripheral artery disease, coronary artery disease, angina, ischemic heart failure, transient ischemic attack or ischemic stroke (non-cardioembolic, non-hemorrhagic);
  • Have been admitted to the PREV program;

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CLSC de Lévis - Programme PREV du CISSS de Chaudière-Appalaches
Coordinator of this site? Confirm its status
LévisCanadaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.